Skip to content
COVID19, Medical Health Aged Care

Vaccine Wastage Costs Australia Over $22 Million Each Year – A Breakthrough Solution Emerges

PSS Distributors 2 mins read

The Australian Government spends approximately $446 million per year buying vaccines for the National Immunisation Program Schedule (NIP) – but approximately $22.3 million is lost annually due to cold-chain breaches, according to figures from the World Health Organisation (WHO).

Cold-chain breaches occur when the recommended storage temperature range of between 2°C and 5°C degrees for storage and transportation is not met. Not only do cold-chain breaches add a significant cost to the NIP each year, but they pose a risk to public health as damaged vaccines may be unintentionally administered, potentially compromising the entire immunisation effort.

To help mitigate these losses and safeguard public health, PSS Distributors, leaders in Uninterruptible Power Supply (UPS) technology, has partnered with medical cold-storage manufacturer Vacc-Safe to introduce Vacc-Safe PowerGuard – Australia’s first vaccine refrigerator with an integrated UPS battery backup. This ground-breaking solution ensures vaccines remain stored under optimal conditions – even during power outages – meeting and exceeding stringent government regulations.

"Cold-chain breaches pose a significant risk to the effectiveness of Australia’s National Immunisation Program (NIP) and the loss of over $22 million in vaccines each year is a serious issue we can no longer ignore," Terrence Daniel, General Manager at PSS Distributors.

“The integration of a backup battery into a vaccine-safe refrigerator not only provides peace of mind to healthcare providers and ensures that vaccines remain effective and safe for use, even in the event of a power failure, but also reduces the cost and installation hassle of having to buy and install a separate backup battery, helping to ensure safe access to essential vaccines for all Australians,” he says.

In accordance with government regulations, all vaccines must be stored in a purpose-built vaccine refrigerator that is data-logged and reviewed at least weekly. The Vacc-Safe PowerGuard vaccine refrigerator not only meets these regulations but sets new standards, with additional features such as UPS battery backup, high-precision temperature control, continuous data logging and weekly data-reporting capabilities, as well as a streamlined all-in-one design that eliminates the need to have a separate refrigerator and bulky UPS battery backup system.

The Vacc-Safe PowerGuard vaccine refrigerator is available to pharmacies and healthcare providers nationally on the UPS Distributors’ website.  


About us:

About PSS Distributors:

PSS Distributors is a leading Australian provider of power protection solutions, specialising in UPS systems designed to safeguard businesses from the impact of power disturbances. With a commitment to innovation and customer satisfaction, PSS Distributors continues to empower businesses with reliable, scalable, and cost-effective power backup solutions.

About Vacc-Safe:

Vacc-Safe is a trusted manufacturer of medical-grade refrigeration solutions, specialising in the development of purpose-built vaccine refrigerators that meet government standards for cold-chain management.


Contact details:

For more information or to arrange an interview with Terrence Daniel, General Manager at PSS Distributors, please contact Georgia Madden at georgia@urdigital.com.au or 0424 854 208.

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.